1. Repository of OAI
Ελληνικά   English  

Browsing by Author Fountzilas, G.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 132 to 151 of 168 < previous   next >
TitleAuthor(s)Issue date???itemlist.???
A randomised phase III trial of adjuvant radio-chemotherapy comparing Irinotecan, 5FU and Leucovorin to 5FU and Leucovorin in patients with rectal cancer: a Hellenic Cooperative Oncology Group StudyKalofonos, H. P.; Bamias, A.; Koutras, A.; Papakostas, P.; Basdanis, G.; Samantas, E.; Karina, M.; Misailidou, D.; Pisanidis, N.; Pentheroudakis, G.; Economopoulos, T.; Papadimitriou, C.; Skarlos, D. V.; Pectasides, D.; Stavropoulos, M.; Bafaloukos, D.; Kardamakis, D.; Karanikiotis, C.; Vourli, G.; Fountzilas, G.24-Nov-2015-
Randomized comparison of early versus late hyperfractionated thoracic irradiation concurrently with chemotherapy in limited disease small-cell lung cancer: A randomized phase II study of the Hellenic Cooperative Oncology Group (HeCOG)Skarlos, D. V.; Samantas, E.; Briassoulis, E.; Panoussaki, E.; Pavlidis, N.; Kalofonos, H. P.; Kardamakis, D.; Tsiakopoulos, E.; Kosmidis, P.; Tsavdaridis, D.; Tzitzikas, J.; Tsekeris, P.; Kouvatseas, G.; Zamboglou, N.; Fountzilas, G.24-Nov-2015-
A randomized open-label parallel-group study comparing ondansetron with ondansetron plus dexamethasone in patients with metastatic breast cancer receiving high-dose epirubicin. A Hellenic Cooperative Oncology Group studyJaninis, J.; Giannakakis, T.; Athanasiadis, A.; Fountzilas, G.; Bafaloukos, D.; Kosmidis, P.; Nikolaides, K.; Pavlidis, N.; Skarlos, D.24-Nov-2015-
A randomized phase II study of carboplatin plus pegylated liposomal doxorubicin versus carboplatin plus paclitaxel in platinum sensitive ovarian cancer patients: a Hellenic Cooperative Oncology Group studyBafaloukos, D.; Linardou, H.; Aravantinos, G.; Papadimitriou, C.; Bamias, A.; Fountzilas, G.; Kalofonos, H. P.; Kosmidis, P.; Timotheadou, E.; Makatsoris, T.; Samantas, E.; Briasoulis, E.; Christodoulou, C.; Papakostas, P.; Pectasides, D.; Dimopoulos, A. M.24-Nov-2015-
A randomized phase III study comparing three anthracycline-free taxane-based regimens, as first line chemotherapy, in metastatic breast cancer: a Hellenic Cooperative Oncology Group studyFountzilas, G.; Dafni, U.; Dimopoulos, M. A.; Koutras, A.; Skarlos, D.; Papakostas, P.; Gogas, H.; Bafaloukos, D.; Kalogera-Fountzila, A.; Samantas, E.; Briasoulis, E.; Pectasides, D.; Maniadakis, N.; Matsiakou, F.; Aravantinos, G.; Papadimitriou, C.; Karina, M.; Christodoulou, C.; Kosmidis, P.; Kalofonos, H. P.24-Nov-2015-
A randomized phase III study of adjuvant platinum/docetaxel chemotherapy with or without radiation therapy in patients with gastric cancerBamias, A.; Karina, M.; Papakostas, P.; Kostopoulos, I.; Bobos, M.; Vourli, G.; Samantas, E.; Christodoulou, Ch; Pentheroudakis, G.; Pectasides, D.; Dimopoulos, M. A.; Fountzilas, G.24-Nov-2015-
A randomized phase III trial of adjuvant chemotherapy with irinotecan, leucovorin and fluorouracil versus leucovorin and fluorouracil for stage II and III colon cancer: a Hellenic Cooperative Oncology Group studyPapadimitriou, C. A.; Papakostas, P.; Karina, M.; Malettou, L.; Dimopoulos, M. A.; Pentheroudakis, G.; Samantas, E.; Bamias, A.; Miliaras, D.; Basdanis, G.; Xiros, N.; Klouvas, G.; Bafaloukos, D.; Kafiri, G.; Papaspirou, I.; Pectasides, D.; Karanikiotis, C.; Economopoulos, T.; Efstratiou, I.; Korantzis, I.; Pisanidis, N.; Makatsoris, T.; Matsiakou, F.; Aravantinos, G.; Kalofonos, H. P.; Fountzilas, G.24-Nov-2015-
A randomized study of epirubicin monotherapy every four or every two weeks in advanced breast cancer. A Hellenic Cooperative Oncology Group studyFountzilas, G.; Athanassiades, A.; Giannakakis, T.; Briasoulis, E.; Bafaloukos, D.; Kalogera-Fountzila, A.; Onienaoum, A.; Kalofonos, H.; Pectasides, D.; Andreopoulou, E.; Bamia, C.; Kosmidis, P.; Pavlidis, N.; Skarlos, D.24-Nov-2015-
A randomized trial to compare the efficacy and safety of antiemetic treatment with ondansetron and ondansetron zydis in patients with breast cancer treated with high-dose epirubicinPectasides, D.; Dafni, U.; Aravantinos, G.; Timotheadou, E.; Skarlos, D. V.; Pavlidis, N.; Gaglia, A.; Kalofonos, H. P.; Fountzilas, G.24-Nov-2015-
Recombinant interferon ALFA-2A in combination with carboplatin, vinblastine, and bleomycin in the treatment of advanced malignant melanomaBafaloukos, D.; Pavlidis, N.; Fountzilas, G.; Skarlos, D.; Klouvas, G.; Makrantonakis, P.; Giannakakis, T.; Tsavaris, N.; Kosmidis, P.24-Nov-2015-
Rituximab in combination with CNOP chemotherapy in patients with previously untreated indolent non-Hodgkin's lymphomaEconomopoulos, T.; Fountzilas, G.; Pavlidis, N.; Kalantzis, D.; Papageorgiou, E.; Christodoulou, C.; Hamilos, G.; Nicolaides, C.; Dimopoulos, M.24-Nov-2015-
The role of soluble interleukin-2 (SIL-2R) receptors as a tumor marker in patients with advanced colorectal cancer (ACC)Pavlidis, N.; Bairaktari, E.; Nicolaides, C.; KalefEzra, J.; Athanassiadis, A.; Seferiadis, C.; Fountzilas, G.24-Nov-2015-
Serum soluble interleukin-2 receptors in epithelial ovarian cancer patientsPavlidis, N. A.; Bairaktari, E.; Kalef-Ezra, J.; Nicolaides, C.; Seferiadis, C.; Fountzilas, G.24-Nov-2015-
Soluble interleukin-2 receptors in patients with advanced colorectal carcinomaPavlidis, N.; Nicolaides, C.; Bairaktari, E.; Kalef-Ezra, J.; Athanassiadis, A.; Seferiadis, C.; Fountzilas, G.24-Nov-2015-
Soluble interleukin-2 receptors in patients with advanced colorectal carcinomaPavlidis, N.; Nicolaides, C.; Bairaktari, E.; KalefEzra, J.; Athanassiadis, A.; Seferiadis, C.; Fountzilas, G.24-Nov-2015-
Subcutaneous low doses of interleukin-2 and recombinant interferon alpha with carboplatin and vinblastine in patients with advanced melanomaBafaloukos, D.; Fountzilas, G.; Skarlos, D.; Pavlidis, N.; Bakoyiannis, C.; Karvounis, N.; Kosmidis, P.24-Nov-2015-
Subsets of tumors responsive to cisplatin or carboplatin combinations in patients with carcinoma of unknown primary site. A Hellenic Cooperative Oncology Group StudyPavlidis, N.; Kosmidis, P.; Skarlos, D.; Briassoulis, E.; Beer, M.; Theoharis, D.; Bafaloukos, D.; Maraveyas, A.; Fountzilas, G.24-Nov-2015-
Survivin and glycodelin transcriptional activity in node-positive early breast cancer: mRNA expression of two key regulators of cell survivalKostadima, L.; Pentheroudakis, G.; Fountzilas, G.; Dimopoulos, M.; Pectasides, D.; Gogas, H.; Stropp, U.; Christodoulou, C.; Samantas, E.; Wirtz, R.; Hennig, G.; Bafaloukos, D.; Arapantoni, P.; Kalofonos, H.; Papakostas, P.; Economopoulos, T.; Bamias, A.; Pavlidis, N.24-Nov-2015-
Targeting c-KIT, PDGFR in cancer of unknown primary: a screening study for molecular markers of benefitDova, L.; Pentheroudakis, G.; Golfinopoulos, V.; Malamou-Mitsi, V.; Georgiou, I.; Vartholomatos, G.; Ntemou, A.; Fountzilas, G.; Pavlidis, N.24-Nov-2015-
Topoisomerase I but not thymidylate synthase is associated with improved outcome in patients with resected colorectal cancer treated with irinotecan containing adjuvant chemotherapyKostopoulos, I.; Karavasilis, V.; Karina, M.; Bobos, M.; Xiros, N.; Pentheroudakis, G.; Kafiri, G.; Papakostas, P.; Vrettou, E.; Fountzilas, G.24-Nov-2015-
Showing results 132 to 151 of 168 < previous   next >